Anti Diabetics are the drugs which stabilise the glucose levels in blood. These medicines also control and lower the levels of glucose in blood for diabetic patients. Most common type of anti diabetics is insulin. A periodic shot of insulin generally long acting type is prescribed for diabetic patients to regulate glucose levels. 

Increasing number of diabetic patients is increasing the demand for anti-diabetics which is a driving factor for anti-diabetics market. Increased use of insulin is a growth factor for this market. Insulin leads the global market with the largest market share by revenue and anticipated to have sharp growth. Increase in rates of obesity is obliquely driving the antidiabetics market. North America hold the largest share in antidiabetics market as it holds highest rate of obesity in the world, which is one of the major reason for cause of diabetics.

The global anti-diabetics market was valued at US$ 143.50 million in 2028 and is expected to grow at a CAGR of more than 9.5% during the forecast period.

The global antidiabetics market is segmented based on its product which include thiazolodinediones, glp-agonists, sulphonylureas, dpp-4 inhibitors, sglt-2, alpha-glucosidase inhibitors, biguanides and meglitinides. The insulin is segmented as rapid acting, long acting, premixed, premixed analog, short acting and intermediate acting. The market segments in terms of geographical regions include North America, Europe, Asia-Pacific and Rest of the World (ROW).

This report provides: 

1) An overview of the global market for anti diabetics market and related technologies.

2) Analyses of global market trends, with data from 2019, estimates for 2020 and 2021, and projections of compound annual growth rates (CAGRs) through 2027.

3) Identifications of new market opportunities and targeted promotional plans for anti diabetics market.

4) Discussion of research and development, and the demand for new products and new applications.

5) Comprehensive company profiles of major players in the industry. 

REPORT SCOPE: 

The scope of the report includes a detailed study of global and regional markets for various types of coatings with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Sanofi-Aventis, Eli Lilly, Oramed Pharmaceuticals, Boehringer Ingelheim, Merck & Co. Inc., Bristol-Myers Squibb, Novo Nordisk, Halozyme Therapeutics, Pfizer and Takeda Pharmaceuticals. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments. 

The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players. 

The Anti Diabetics Market has been segmented as below:  

by Types of Insulin

• Rapid Acting

• Long Acting

• Premixed

• Premixed Analog

• Short Acting

• Intermediate Acting

by Product

• Biguanides

• Thiazolodinediones

• GLP-agonists

• Sulphonylureas

• DPP-4 inhibitors

• SGLT-2

• Alpha-glucosidase Inhibitors

• Meglitinides

by Geography

• North America

• Europe

• Asia-Pacific

• Rest of the World (ROW)

Customization: 

We can offer you custom research reports as per client’s special requirements.

Below are our New Reports :-

Mouth Ulcers Drugs market

muscle relaxants market

Nanostructured Drug Market

Nasal Drug Delivery Technology Market 

Nasal Spray Market